US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Clovis Oncology Inc (CLVS)
Clovis Oncology Inc (CLVS) ニュース

CLVS

Clovis Oncology (CLVS)

Clovis Oncology Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLVS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/05/02	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/04/14	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/04/07	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/03/02	22 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/02/17	06 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/02/13	20 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2023/02/10	23 : 49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CLVS	Clovis Oncology Inc
2023/01/12	20 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/29	23 : 36	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/13	20 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/13	20 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/12	20 : 54	Dow Jones News	Clovis Oncology Shares Fall Premarket After Bankruptcy Filing	NASDAQ:CLVS	Clovis Oncology Inc
2022/12/12	14 : 18	Business Wire	Clovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/17	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/09	22 : 12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05 : 18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/11/04	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/28	06 : 05	Business Wire	Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/17	16 : 45	Business Wire	Clovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM Congress	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/05	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/10/03	20 : 00	Business Wire	TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/21	21 : 00	Business Wire	Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/13	21 : 00	Business Wire	Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/12	20 : 55	TipRanks	Clovis (NASDAQ:CLVS) Jumps After Rubraca Shows Progression-Free Survival in Ovarian Cancer	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/11	23 : 30	Business Wire	Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc
2022/09/07	05 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLVS	Clovis Oncology Inc

Showing the most relevant articles for your search:NASDAQ:CLVS

1 2 3 4 5 6 7 8 9 10 次へ >>

CalciMedica (QB)

Morgan Stanley Finance L...

Volkswagen Bank

RXR Acquisition

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約